Showing 7221-7230 of 10620 results for "".
- Spinal Muscular Atrophy: New Possibilities with Prenatal Interventionshttps://reachmd.com/news/spinal-muscular-atrophy-new-possibilities-with-prenatal-interventions/2476045/Spinal Muscular Atrophy (SMA), a devastating genetic disorder, is revealing new possibilities for prenatal intervention as clinicians are leveraging injections of therapeutic agents into the amniotic fluid to alter its course before birth. Understanding these interventions begins wit
- Advancing Fluid Management in Sepsis with Non-Invasive Cardiac Output Monitoringhttps://reachmd.com/news/advancing-fluid-management-in-sepsis-with-non-invasive-cardiac-output-monitoring/2476013/Fluid management in sepsis often hinges on accurate assessment of fluid responsiveness, yet reliance on static measures (as recommended against in the Surviving Sepsis Campaign 2024) can mislead resuscitation strategies. Non-invasive cardiac output monitoring (NICOM) is emerging as an innov
- Addressing Ethnic and Biological Disparities in Cardiovascular Carehttps://reachmd.com/news/addressing-ethnic-and-biological-disparities-in-cardiovascular-care/2476020/Cardiovascular disease remains a leading cause of mortality worldwide, and emerging data reveal that outcomes are profoundly shaped by ethnic disparities, biological processes like inflammation, and the nuances of post-event recovery. Recent findings in the
- Emerging Insights into HTLV-1 Persistence and Therapeutic Advanceshttps://reachmd.com/news/emerging-insights-into-htlv-1-persistence-and-therapeutic-advances/2476004/Human T-cell leukemia virus type 1 (HTLV-1) persistence hinges on its capacity to enter latency, evading immune detection and complicating efforts to eradicate infected cells. Recent discoveries reveal a
- Enhancing Emergency Medicine's Role in Early MS Diagnosishttps://reachmd.com/news/enhancing-emergency-medicines-role-in-early-ms-diagnosis/2476002/Enhancing the role of emergency medicine in the early diagnosis of multiple sclerosis (MS) through the recognition of subtle signs and integrative diagnostic techniques can lead to better patient management and outcomes. Emerging evidence shows that
- Addressing Vitamin A Deficiencies: A Public Health Imperativehttps://reachmd.com/news/addressing-vitamin-a-and-magnesium-deficiencies-a-public-health-imperative/2476003/Despite global efforts, vitamin A deficiency remains a leading cause of preventable childhood morbidity and mortality in low-resource regions such as Kasaï-Oriental province of the Democratic Republic of the Congo
- Addressing Pediatric Antimicrobial Resistance in Ghana: Strategies and Solutionshttps://reachmd.com/news/addressing-pediatric-antimicrobial-resistance-in-ghana-strategies-and-solutions/2475993/Antimicrobial resistance among Ghanaian children is escalating into a silent crisis, with ward-level audits reporting high rates of inappropriate pediatric antibiotic use. Clinicians wrestle with empiric therapy decisions for neonatal sepsis and pneumonia management amid limited diag
- Evolving Strategies in Alzheimer's and Stroke Recovery: New Insights and Innovationshttps://reachmd.com/news/evolving-strategies-in-alzheimers-and-stroke-recovery-new-insights-and-innovations/2475994/Leqembi’s demonstration of slowed cognitive decline in early Alzheimer’s disease represents a paradigm shift in addressing an unmet need for disease-modifying therapies, as shown in the
- Mitochondrial Revolution in Neurology: A Paradigm Shift for Disease Managementhttps://reachmd.com/news/mitochondrial-revolution-in-neurology-a-paradigm-shift-for-disease-management/2476043/The pursuit of novel therapies in neurology is increasingly focusing on how mitochondrial energy homeostasis and oxidative stress regulation dictate neuronal survival, shifting the paradigm for conditions from spinal muscular atrophy to autism and suggesting that harnessing mitochon
- Nirsevimab: A Turning Point in RSV Prophylaxis for Infantshttps://reachmd.com/news/nirsevimab-a-turning-point-in-rsv-prophylaxis-for-infants/2475966/Respiratory syncytial virus continues to drive significant morbidity in infants, yet prevention efforts have lagged behind advances in treatment, leaving a critical window of vulnerability in the youngest patients. For pediatric infectious disease specialists, the advent of long-acti